Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L02AE04 TRIPTORELINUM LIOF. + SOLV. PT. SOL. 0.1 mg

INJ.

DIPHERELINE 0,1 mg 0.1 mg BEAUFOUR IPSEN PHARMA

L02AE04 TRIPTORELINUM LIOF. + SOLV. PT. SUSP. 11.25 mg

INJ. I.M. ELIB. PREL.

DIPHERELINE(R) 11,25 mg 11.25 mg BEAUFOUR IPSEN PHARMA
L02AE04 TRIPTORELINUM LIOF. + SOLV. PT. SUSP. 3.75 mg

INJ. I.M. ELIB. PREL.

DIPHERELINE(R) 3,75 mg 3.75 mg BEAUFOUR IPSEN PHARMA

________________________________________________________________________________

______________________________________________________________________________

| 764 |L02BA01| TAMOXIFENUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L02BA01 TAMOXIFENUM COMPR. 10 mg

TAMONEPRIN(R) 10 mg 10 mg ACTAVIS S.R.L.

TAMOXIFEN 10 TEVA 10 mg PHARMACHEMIE BV

L02BA01 TAMOXIFENUM COMPR. FILM. 10 mg

TAMOXIFEN(R) 10 HEXAL 10 mg HEXAL AG

________________________________________________________________________________
______________________________________________________________________________

| 765 |L02BA03| FULVESTRANTUM** | Protocol: L003C |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L02BA03 FULVESTRANTUM SOL. INJ. 250 mg/5 ml

FASLODEX 250 mg/5 ml 250 mg/5 ml ASTRAZENECA UK LTD.

________________________________________________________________________________

______________________________________________________________________________

| 766 |L02BB01| FLUTAMIDUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L02BB01 FLUTAMIDUM COMPR. 250 mg

FLUTAN 250 mg MEDOCHEMIE LTD.

FLUTASIN(R) 250 mg 250 mg ACTAVIS S.R.L.

________________________________________________________________________________
______________________________________________________________________________

| 767 |L02BB03| BICALUTAMIDUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L02BB03 BICALUTAMIDUM COMPR. FILM. 150 mg

CASODEX 150 mg 150 mg ASTRAZENECA UK LTD.
L02BB03 BICALUTAMIDUM COMPR. FILM. 50 mg

CALUMID 50 mg GEDEON RICHTER PLC.

CASODEX 50 mg 50 mg ASTRAZENECA UK LTD.

________________________________________________________________________________

______________________________________________________________________________

| 768 |L02BG01| AMINOGLUTETHIMIDUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L02BG01 AMINOGLUTETHIMIDUM COMPR. 250 mg

ROGLUTEN(R) 250 mg 250 mg ACTAVIS S.R.L.

________________________________________________________________________________

______________________________________________________________________________

| 769 |L02BG03| ANASTROZOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L02BG03 ANASTROZOLUM COMPR. FILM. 1 mg

ARIMIDEX 1 mg ACTAVIS S.R.L.

ARIMIDEX 1 mg 1 mg ASTRAZENECA UK LTD.

________________________________________________________________________________
______________________________________________________________________________

| 770 |L02BG04| LETROZOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L02BG04 LETROZOLUM COMPR. FILM. 2.5 mg

FEMARA 2,5 mg 2.5 mg NOVARTIS PHARMA GMBH

________________________________________________________________________________

______________________________________________________________________________

| 771 |L02BG06| EXEMESTANUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L02BG06 EXEMESTANUM DRAJ. 25 mg

AROMASIN 25 mg 25 mg PFIZER EUROPE MA EEIG

________________________________________________________________________________

______________________________________________________________________________

| 772 |L03AA02| FILGRASTIMUM (G-CSF)** | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Reducerea duratei neutropeniei şi a incidenţei neutropeniei febrile la pacienţii trataţi cu chimioterapie citotoxică standard pentru bolile maligne (cu excepţia leucemiei mieloide cronice şi a sindroamelor mielodisplazice), precum şi pentru reducerea duratei neutropeniei la pacienţii care primesc terapie mieloablativă urmată de transplant de măduvă osoasă.